Small Molecule EGFR Inhibitors as Anti-Cancer Agents: Discovery, Mechanisms of Action, and Opportunities

Epidermal growth factor receptors (EGFRs) are a class of receptor tyrosine kinase that are also called ErbB1 and HER1. EGFR tyrosine kinase activity inhibition is considered a promising therapeutic strategy for the treatment of cancer. Many small-molecule inhibitors of EGFR tyrosine kinase (EGFR-TK)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zubair, Tanzida, Bandyopadhyay, Debasish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916655/
https://www.ncbi.nlm.nih.gov/pubmed/36768973
http://dx.doi.org/10.3390/ijms24032651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916655/
https://www.ncbi.nlm.nih.gov/pubmed/36768973
http://dx.doi.org/10.3390/ijms24032651

Ejemplares similares